Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 866.75
-4.05 (-0.47%)
Apr 17, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 18.27 billion as of April 17, 2026. Its market cap has decreased by -11.69% in one year.
Market Cap
18.27B
Enterprise Value
15.97B
Revenue
8.68B
Ranking
n/a
PE Ratio
27.57
Stock Price
866.75
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 18.27B, an increase of 105.88%. That is a compound annual growth rate of 16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 18.27B | 9.63% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 48.03B |
| Innova Captab | 42.48B |
| RPG Life Sciences | 33.48B |
| Orchid Pharma | 28.88B |
| Solara Active Pharma Sciences | 24.04B |
| Indoco Remedies | 20.27B |
| Beta Drugs | 13.89B |
| Sakar Healthcare | 13.21B |